Development of a patient decision aid for choice of surgical treatment for breast cancer
Sawka CA, Goel V, Mahut CA, Taylor GA, Thiel EC, O'Connor AM, Ackerman I, Burt JH, Gort EH. Health Expect. 1998; 1(1):23-36.
Publications
Enthusiasm or uncertainty: small area variations in the use of mammography services in Ontario, Canada
Goel V, Iron K, Williams JI. J Epidemiol Community Health. 1997; 51(4):378-82.
The rise of tamoxifen: temporal and geographical trends of tamoxifen use in Ontario
Palda VA, Goel V, Sawka CA. Breast Cancer Res Treat. 1997; 43(1):33-41.
Physicians’ opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer
O'Connor AM, Llewellyn-Thomas HA, Sawka C, Pinfold SP, To T, Harrison DE. Patient Educ Couns. 1997; 30(2):143-53.
Patterns of initial management of node-negative breast cancer in two Canadian provinces
Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ. CMAJ. 1997; 156(1):25-35.
Compliance with practice guidelines for node-negative breast cancer
Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C. J Clin Oncol. 1997; 15(1):216-22.
The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer
Sawka C, Olivotto I, Coldman A, Goel V, Holowaty E, Hislop TG. Br J Cancer. 1997; 75(10):1534-42.
Using an alternative data source to examine randomization in the Canadian National Breast Screening Study
Cohen MM, Kaufert PA, MacWilliam L, Tate RB. Clin Epidemiol. 1996; 49(9):1039-44.
Risk factors for breast cancer mortality among the National Breast Screening Study of Canada participants
Busetti MC, Miller AB, To T, Rohan TE. Cancer Detect Prev. 1996; 20(2):122-9.
Variations in hysterectomy rates in Ontario: does the indication matter?
Hall RE, Cohen MM. CMAJ. 1994; 151(12):1713-9.